Stockreport

Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%? [Yahoo! Finance]

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF NASDAQ:COLL Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Put another way, it reveals the company [Read more]